As of September 09, 2026, BioRestorative Therapies's top three insider holders are Dale Broadrick (TenPercentOwner, 869.90K shares), Dale Broadrick (TenPercentOwner, 445.93K shares), Dale Broadrick (TenPercentOwner, 317.97K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Dale Broadrick | TenPercentOwner | 445,933 | 0 | 445,933 | 46.0% | 04 Nov, 2024 |
| 2 | Francisco Silva | Vp Of Research And Development | 327,143 | 0 | 327,143 | 33.8% | 17 Oct, 2025 |
| 3 | Lance Alstodt | President, Ceo, Cob | 187,497 | 0 | 187,497 | 19.4% | 17 Oct, 2025 |
| 4 | Robert Eugene Kristal | Chief Financial Officer | 7,994 | 0 | 7,994 | 0.8% | 15 Jun, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 06 Oct, 2025 | Francisco Silva | Vp Of Research And Development | Acquired A | 11,719 | $1.60 | $18.75K | 171,384 | Direct |
| 06 Oct, 2025 | Lance Alstodt | President, Ceo, Cob | Acquired A | 15,625 | $1.60 | $25.00K | 187,497 | Direct |
| 06 Oct, 2025 | Francisco Silva | Vp Of Research And Development | Acquired A | 11,719 | $1.60 | $18.75K | 171,384 | Direct |
| 06 Oct, 2025 | Francisco Silva | Vp Of Research And Development | Acquired A | 11,719 | $1.60 | $18.75K | 171,384 | Direct |
| 06 Oct, 2025 | Lance Alstodt | President, Ceo, Cob | Acquired A | 11,719 | $0.00 | $0 | 11,719 | Direct |
| 06 Oct, 2025 | Francisco Silva | Vp Of Research And Development | Acquired A | 11,719 | $0.00 | $0 | 11,719 | Direct |
| 06 Oct, 2025 | Francisco Silva | Vp Of Research And Development | Acquired A | 11,719 | $0.00 | $0 | 11,719 | Direct |
| 06 Oct, 2025 | Francisco Silva | Vp Of Research And Development | Acquired A | 11,719 | $0.00 | $0 | 11,719 | Direct |
| 14 Feb, 2025 | Nickolay V. Kukekov | Director | Acquired A | 52,632 | $0.00 | $0 | 52,632 | Direct |
| 14 Feb, 2025 | Nickolay V. Kukekov | Director | Acquired A | 52,632 | $0.00 | $0 | 52,632 | Direct |
| 14 Feb, 2025 | Nickolay V. Kukekov | Director | Acquired A | 52,632 | $0.00 | $0 | 52,632 | Direct |
| 14 Feb, 2025 | Robert Eugene Kristal | Chief Financial Officer | Acquired A | 166,492 | $0.00 | $0 | 166,492 | Direct |
| 14 Feb, 2025 | Robert Eugene Kristal | Chief Financial Officer | Acquired A | 166,492 | $0.00 | $0 | 166,492 | Direct |
| 14 Feb, 2025 | Robert Eugene Kristal | Chief Financial Officer | Acquired A | 166,492 | $0.00 | $0 | 166,492 | Direct |
| 14 Feb, 2025 | Lance Alstodt | President, Ceo, Cob | Acquired A | 791,885 | $0.00 | $0 | 791,885 | Direct |
| 14 Feb, 2025 | Francisco Silva | Vp Of Research And Development | Acquired A | 768,979 | $0.00 | $0 | 768,979 | Direct |
| 14 Feb, 2025 | Francisco Silva | Vp Of Research And Development | Acquired A | 768,979 | $0.00 | $0 | 768,979 | Direct |
| 14 Feb, 2025 | Francisco Silva | Vp Of Research And Development | Acquired A | 768,979 | $0.00 | $0 | 768,979 | Direct |
| 28 Oct, 2024 | Dale Broadrick | TenPercentOwner | Disposed S | 1,112 | $1.58 | $1.76K | 445,933 | Direct |
| 28 Oct, 2024 | Dale Broadrick | TenPercentOwner | Disposed S | 1,112 | $1.58 | $1.76K | 445,933 | Direct |